AMRI Financial Facts

Loss from operations: 9.4M
Other (expense) income, net: 452K
See Full Income Statement

Property and equipment, net: 132.88M
Total liabilities and stockholders' equity: 270M
See Full Balance Sheet

Earnings History for Albany Molecular Research Inc. (AMRI)

  |   Expand Research on AMRI
Next EPS Date 7/31/13 *Est. EPS Growth Rate +1,050.0% *Last Qtr.
Average EPS % Beat Rate +82.2% Revenue Growth Rate +10.6% *Last Qtr.
Average % Move 1-Wk after EPS +13.4%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/7/13 Q113 $0.23N/A N/A $59.4M$53.7M N/A / N/A = -14.6% Details
2/12/13 Q412 $0.17$0.09 +$0.08$59.1M$56.49M N/A / N/A = +84.6% Details
11/6/12 Q312 $0.00-$0.02 +$0.02$55.8M$50.8M N/A / N/A = +202.9% Details
8/1/12 Q212 $0.06$0.02 +$0.04$50M$52M N/A / N/A = +269.3% Details
5/9/12 Q112 $0.02$0.05 -$0.03$53.7M$52.12M N/A / N/A = +247.2% Details
2/7/12 Q411 -$0.19N/A N/A $46.6M$48.6M N/A / N/A = +238.2% Details
11/8/11 Q311 -$0.19N/A N/A $50.23M$50.62M N/A / N/A = +227.6% Details
8/8/11 Q211 -$0.02-$0.03 +$0.01$53.9M$52.42M N/A / N/A = +139.7% Details
Like AMRI Earnings? Also take a look at NLNK, NDAQ, PGNX, SCMP

AMRI Earnings News